323 related articles for article (PubMed ID: 28101622)
1. [Use of vasopressors and inotropics in cardiogenic shock].
Lemm H; Dietz S; Janusch M; Buerke M
Herz; 2017 Feb; 42(1):3-10. PubMed ID: 28101622
[TBL] [Abstract][Full Text] [Related]
2. [Modern drug therapy in cardiovascular intensive care medicine].
Lemm H; Dietz S; Janusch M; Buerke M
Internist (Berl); 2015 Jun; 56(6):702, 704-8, 710-2. PubMed ID: 26054838
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic support in cardiogenic shock.
Rude RE
Adv Shock Res; 1983; 10():35-49. PubMed ID: 6349299
[TBL] [Abstract][Full Text] [Related]
4. The medical treatment of cardiogenic shock: cardiovascular drugs.
De Backer D; Arias Ortiz J; Levy B
Curr Opin Crit Care; 2021 Aug; 27(4):426-432. PubMed ID: 33797431
[TBL] [Abstract][Full Text] [Related]
5. Current real-life use of vasopressors and inotropes in cardiogenic shock - adrenaline use is associated with excess organ injury and mortality.
Tarvasmäki T; Lassus J; Varpula M; Sionis A; Sund R; Køber L; Spinar J; Parissis J; Banaszewski M; Silva Cardoso J; Carubelli V; Di Somma S; Mebazaa A; Harjola VP;
Crit Care; 2016 Jul; 20(1):208. PubMed ID: 27374027
[TBL] [Abstract][Full Text] [Related]
6. Inotropes and vasopressors use in cardiogenic shock: when, which and how much?
Levy B; Buzon J; Kimmoun A
Curr Opin Crit Care; 2019 Aug; 25(4):384-390. PubMed ID: 31166204
[TBL] [Abstract][Full Text] [Related]
7. Cardiogenic shock: Inotropes and vasopressors.
Amado J; Gago P; Santos W; Mimoso J; de Jesus I
Rev Port Cardiol; 2016 Dec; 35(12):681-695. PubMed ID: 27836218
[TBL] [Abstract][Full Text] [Related]
8. [Management of cardiogenic shock: Results from a survey in France and Belgium].
Champion S; Deye N
Ann Cardiol Angeiol (Paris); 2017 Apr; 66(2):59-65. PubMed ID: 27836099
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan as rescue therapy in severe cardiogenic shock after ST-elevation myocardial infarction.
Greif M; Zwermann L; Reithmann C; Weis M
Acute Card Care; 2008; 10(3):185-90. PubMed ID: 18972629
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic therapies for acute cardiogenic shock.
Nativi-Nicolau J; Selzman CH; Fang JC; Stehlik J
Curr Opin Cardiol; 2014 May; 29(3):250-7. PubMed ID: 24686400
[TBL] [Abstract][Full Text] [Related]
11. Vasoactive drugs in circulatory shock.
Hollenberg SM
Am J Respir Crit Care Med; 2011 Apr; 183(7):847-55. PubMed ID: 21097695
[TBL] [Abstract][Full Text] [Related]
12. Inotropic Agents and Vasopressors in the Treatment of Cardiogenic Shock.
Shabana A; Dholoo F; Banerjee P
Curr Heart Fail Rep; 2020 Dec; 17(6):438-448. PubMed ID: 33103204
[TBL] [Abstract][Full Text] [Related]
13. Levosimendan in the treatment of cardiogenic shock.
Buerkem B; Lemm H; Krohe K; Dietz S; Raaz U; Buerke U; Russ M; Schlitt A; Werdan K
Minerva Cardioangiol; 2010 Aug; 58(4):519-30. PubMed ID: 20938415
[TBL] [Abstract][Full Text] [Related]
14. Cardiogenic shock after primary percutaneous coronary intervention: Effects of levosimendan compared with dobutamine on haemodynamics.
García-González MJ; Domínguez-Rodríguez A; Ferrer-Hita JJ; Abreu-González P; Muñoz MB
Eur J Heart Fail; 2006 Nov; 8(7):723-8. PubMed ID: 16492404
[TBL] [Abstract][Full Text] [Related]
15. Right ventricular function in myocardial infarction complicated by cardiogenic shock: Improvement with levosimendan.
Russ MA; Prondzinsky R; Carter JM; Schlitt A; Ebelt H; Schmidt H; Lemm H; Heinroth K; Soeffker G; Winkler M; Werdan K; Buerke M
Crit Care Med; 2009 Dec; 37(12):3017-23. PubMed ID: 19661807
[TBL] [Abstract][Full Text] [Related]
16. Vasopressors and Inotropes as Predictors of Mortality in Acute Severe Cardiogenic Shock Treated With the Impella Device.
Rohm CL; Gadidov B; Ray HE; Mannino SF; Prasad R
Cardiovasc Revasc Med; 2021 Oct; 31():71-75. PubMed ID: 33309042
[TBL] [Abstract][Full Text] [Related]
17. The effects of Levosimendan on global haemodynamics in patients with cardiogenic shock.
Rokyta R; Pechman V
Neuro Endocrinol Lett; 2006; 27(1-2):121-7. PubMed ID: 16648778
[TBL] [Abstract][Full Text] [Related]
18. Effects of levosimendan versus dobutamine on left ventricular diastolic function in patients with cardiogenic shock after primary angioplasty.
Dominguez-Rodriguez A; Samimi-Fard S; Garcia-Gonzalez MJ; Abreu-Gonzalez P
Int J Cardiol; 2008 Aug; 128(2):214-7. PubMed ID: 17643535
[TBL] [Abstract][Full Text] [Related]
19. Continuous levosimendan infusion for refractory cardiogenic shock complicating severe acute dichlorvos poisoning.
Liu Y; Liu B; Zhou H; Wei LQ
Am J Med Sci; 2012 Aug; 344(2):166-70. PubMed ID: 22771967
[TBL] [Abstract][Full Text] [Related]
20. Cardiogenic shock.
Rackley CE; Russell RO; Mantle JA; Rogers WJ
Cardiovasc Clin; 1981; 11(3):15-24. PubMed ID: 7214388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
